Canadian Tuberculosis Committee (CTC)

• Canadian Tuberculosis Committee (CTC)
  
• • Membership
  • Terms of Reference

• Aboriginal Tuberculosis Scientific Subcommittee of the Canadian Tuberculosis Committee
• Immigration Sub-Committee of the Canadian Tuberculosis Committee (CTC)

• Surveillance Sub-Committee of the Canadian Tuberculosis Committee (CTC)

• Metropolitan Tuberculosis Issues Subcommittee of the Canadian Tuberculosis Committee (CTC)

• Statement of Data Sharing, Authorship and Publication

---

Canadian Tuberculosis Committee (CTC) Membership List

Provincial/Territorial TB Control Program Representatives

Alberta
Dr. Richard Long
University of Alberta

British Columbia
Dr. Kevin Elwood
Director, Division of TB Control
BC Centre for Disease Control

Manitoba
Dr. Joel Kettner
Chief Medical Officer of Health

New Brunswick
Ms. Eileen McQuade
Program Consultant
Office of the Chief Medical Officer of Health
Department of Health

Newfoundland and Labrador
Ms. Marion Yetman
Department of Health and Community Services

Nova Scotia
Ms. Dee Mombourquette
Communicable Disease Coordinator
Nova Scotia Health Promotion and Protection

Northwest Territories
Ms. Cheryl Case
Communicable Disease Consultant
Office of the Chief Medical Health Officer
Department of Health and Social Services

Nunavut
Ms. Elaine Randell
Communicable Disease Consultant II
Health Protection Unit
Department of Health and Social Services

Ontario
Dr. George Samuel
Senior Medical Consultant
TB/Respiratory Program
Infectious Disease Branch, Public Health Division
Ontario Ministry of Health and Long-Term Care

Prince Edward Island
Dr. Heather Morrison
Chief Health Officer
Department of Health

Québec  (Chair)
Dr. Paul Rivest
Médecin conseil, Tuberculose
Ministère de la Santé et des Services sociaux

Saskatchewan
Ms. Diane McDougall
Manager, TB Control Saskatchewan

Yukon
Ms. Cathy Stannard
Yukon Communicable Disease Control

Aboriginal Scientific Subcommittee Chair
Dr. Pamela Orr
Department of Medicine
Health Sciences Centre

Immigration Subcommittee Chair
Dr. Terry-Nan Tannenbaum
Médecin conseil, Immigration Santé
Ministère de la Santé et des Services sociaux

Metropolitan TB Issues Subcommittee Chair
Dr. Kevin Elwood (see British Columbia)

National Reference Centre for Mycobacteriology, National Microbiology Laboratory, Public Health Agency of Canada
Ms. Joyce Wolfe
Program Manager, Mycobacteriology
Canadian Science Centre for Human and Animal Health
Public Health Agency of Canada

First Nations and Inuit Health Branch
Health Canada
Dr. Lilian Yuan
Regional Community Medicine Specialist
First Nations and Inuit Health, Ontario Region
Health Canada

Canadian Public Health Laboratory Network
Dr. Frances Jamieson
Medical Microbiologist, TB and Mycobacteriology
Public Health Laboratories Branch,
Ministry of Health and Long-Term Care

Correctional Service Canada
Ms. Teresa Garrahan
Nursing Officer
Health Services - Public Health
Correctional Service of Canada

Citizenship and Immigration Canada
Dr. Lise Scott
Director General
Health Management Branch
Citizenship and Immigration Canada

Canadian Lung Association
Ms. Debbie Smith
Manager, Health Initiatives
The Lung Association

Association of Medical Microbiology and Infectious Disease Canada
Dr. Wendy Wobeser
Division of Infectious Diseases
Queen's University and Kingston General Hospital

Canadian Thoracic Society
Dr. Heather Ward
Chair, Canadian Thoracic Society, TB committee

Tuberculosis Prevention and Control Public Health Agency of Canada
Dr. Edward Ellis
Manager

Ex-Officio Members
Mr. Derek Scholten
Senior Epidemiologist
Tuberculosis Prevention and Control
Public Health Agency of Canada

---

Canadian Tuberculosis Committee (CTC)

Terms of Reference

Mandate:
To provide scientifically based advice to the Public Health Agency of Canada on Canadian strategies and priorities with respect to tuberculosis prevention and control.

To provide a forum to address issues of common concern related to provincial/territorial
tuberculosis control programs in order to enhance tuberculosis surveillance and control activities in Canada.

The Canadian Tuberculosis Committee has no decision-making authority over programs or regulatory functions, nor is it responsible for the implementation of its advice.

Specific activities include:

1. To review the extent to which progress has been made towards eliminating tuberculosis in Canada.
2. To review and recommend legislation, policies, guidelines and priorities (at the municipal, provincial/territorial and federal levels) to enhance tuberculosis control programs.

3. To review regularly the surveillance requirements for tuberculosis in Canada, including all items reportable to the national level.

4. To review the results of national surveillance activities, including trends in tuberculosis in sub‑populations and drug resistance in Canada, and to make recommendations based on these trends.
5. To make recommendations regarding tuberculosis educational programs for health care providers and the public and other areas in order to enhance tuberculosis control activities.
6. To respond to requests for consultation on specific items, including making recommendations concerning items referred by the Minister of Health, Chief Public Health Officer or Public Health Agency of Canada staff dealing with tuberculosis prevention and control.
7. To address the application of new technologies.
8. To recommend priorities for epidemiological and laboratory tuberculosis research in Canada.

Reporting Relationship:
The Canadian Tuberculosis Committee reports to the Communicable Disease Control Expert Group, an expert group within the Pan-Canadian Public Health Network, through the Director-General, Centre for Communicable Diseases and Infection Control, Public Health Agency of Canada.

Each member also reports to his/her jurisdiction/organization and is responsible for communicating decisions and information of the Committee to their jurisdiction or organization.

Membership:
Members of the Canadian Tuberculosis Committee shall include:

1. One representative from each province/territory (the provincial/territorial "director" of tuberculosis control or their designate).
2. The Manager, Tuberculosis Prevention and Control, Public Health Agency of Canada.
3. The Senior Medical Advisor, National Microbiology Laboratory,  Public Health Agency of Canada.
4. A representative from the Canadian Public Health Laboratory Network (provincial/territorial laboratory directors).
5. The Chairs of the Subcommittees of the Canadian Tuberculosis Committee, if not already members in another capacity.
6. A representative from First Nations and Inuit Health Branch, Health Canada.
7. The Director General, Health Management Branch, Citizenship and Immigration Canada.
8. A representative from the Canadian Lung Association who will also represent Stop TB Canada.
9. The National Infectious Diseases Coordinator, Correctional Service of Canada.
10. A representative from the Association of Medical Microbiology and Infectious Disease.
11. A representative from the Canadian Thoracic Society.
12. Senior Epidemiologist, Tuberculosis Prevention and Control, Public Health Agency of Canada (ex-officio).
13. Other representatives from organizations with interests in the prevention and control of tuberculosis as the Chair and Director General of Centre for Communicable Diseases and Infection Control deem necessary to effectively carry out the function of the committee.

In the exercise of their functions, committee members shall act as recognized experts in their field.  Members will be required to file a confidential financial disclosure report and to declare to the Chair if the committee deliberations place them in a situation of real or perceived conflict of interest (as per the Health Canada Policy Guide for the Management of Advisory Committees).

Committee members are expected to protect and maintain as confidential any classified or otherwise privileged information divulged to them in the course of the committee’s work.

Functioning:
Recommendations and final reports are to be developed by the committee in concert with Tuberculosis Prevention and Control, Public Health Agency of Canada staff at the appropriate working level. These reports are to be submitted by the Committee Executive Secretary for presentation to the Director General of Centre for Communicable Diseases and Infection Control.

All members will have voting privileges except for ex-officio members.  Voting will be by consensus where possible.  In circumstances where consensus is not possible, decisions will be reached by a majority vote of full members including the Chair.  In the event of a tie, the vote is lost.

There are four standing subcommittees of the Canadian Tuberculosis Committee: the Aboriginal Scientific Subcommittee, Immigration Subcommittee, the Metropolitan TB Issues Subcommittee and the Surveillance Subcommittee.

The committee or the Chair may, as the need arises, create working groups to examine specific areas or to develop position papers. The Chair of a working group shall also be a member of the committee.  However, non-committee members and/or external experts may be invited to participate in working groups as required.  Recommendations are to be brought back to the committee as a whole and thus, if approved, to become recommendations of the full committee.

Chair:
The Chair shall be nominated and elected by the members, and shall be a provincial/territorial member of the committee.  The term of the Chair shall be for three (3) years.

Secretariat:
Executive Secretary: Manager, Tuberculosis Prevention and Control, Public Health Agency of Canada

Administrative Secretary: Tuberculosis Prevention and Control, Public Health Agency of Canada staff.

Minutes shall be recorded by staff of Tuberculosis Prevention and Control, Public Health Agency of Canada, and circulated to members prior to the next meeting.  Approved minutes will be forwarded to the Director General of the Centre for Communicable Diseases and Infection Control.

A member may request that significant objections to a Committee decision be included in the minutes and brought to the attention of the Director General of the Centre for Communicable Diseases and Infection Control. 

Advisory Committee Statements, issues (with motions) and deliverables will be forwarded to the Communicable Disease Control Expert Group of the Pan-Canadian Public Health Network for information or approval and/or as a pathway to the Deputy Ministers of Health.

Agenda items shall be identified by any member of the Committee and forwarded to the Chair no less than one month prior to the scheduled meeting date.

Meetings:
Meetings of the full committee shall be held at least once a year. Consideration may be given by Tuberculosis Prevention and Control, Public Health Agency of Canada to fund additional meetings of the full committee and/or any meetings of subcommittees, dependent on the need.  The location of the meeting(s) shall rotate around the country and shall be selected by the committee.

Committee Member Expenses:
The cost of travel and related expenses for committee members shall be borne by Tuberculosis Prevention and Control, Public Health Agency of Canada, and paid in accordance with Treasury Board policies.